SIRT1 regulates the human alveolar epithelial A549 cell apoptosis induced by pseudomonas aeruginosa lipopolysaccharide

Cellular Physiology and Biochemistry

Volumn 31, Issue 1, 2013, Pages 92-101

  Liu, Xiaoli ^a,b   Shao, Kuiqing ^c   Sun, Tieying ^a,b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Apoptosis; LPS; ROS; SIRT1

Indexed keywords

ACETYLCYSTEINE; BACTERIUM LIPOPOLYSACCHARIDE; NICOTINAMIDE; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1;

A549 CELL LINE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84873048259     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343352     Document Type: Article

References (35)

1. Sadikot RT, Blackwell TS, Christman JW, Prince AS: Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005;171:1209-1223.
2. Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System: Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-854.
3. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH, VAP Outcomes Scientific Advisory Group: Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121.
4. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR: New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990;69:307-316.
5. Blanquer J, Blanquer R, Borrs R, Nauffal D, Morales P, Menéndez R, Subas I, Herrero L, Redn J, Pascual J: Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 1991;46:508-511.
6. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, Jackson R, Schousboe M, Frampton C, Hutton S, Chambers ST: Town GI Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010-1016.
7. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER: Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982;126:332-337.
8. Herzog EL, Brody AR, Colby TV, Mason R, Williams MC: Knowns and unknowns of the alveolus. Proc Am Thorac Soc 2008;5:778-782.
9. Chen TG, Chen TL, Chang HC, Tai YT, Cherng YG, Chang YT, Chen RM: Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway. Toxicol Appl Pharmacol 2007;219:42-53.
10. Ferrari R, Ceconi C, Campo G, Cangiano E, Cavazza C, Secchiero P, Tavazzi L: Mechanisms of remodelling: a question of life (stem cell production) and death (myocyte apoptosis). Circ J 2009;73:1973-1982.
11. Arnoult D, Carneiro L, Tattoli I, Girardin SE: The role of mitochondria in cellular defense against microbial infection. Semin Immunol 2009;21:223-232.
12. Rudel T, Kepp O, Kozjak-Pavlovic V: Interactions between bacterial pathogens and mitochondrial cell death pathways. Nat Rev Microbiol 2010;8:693-705.
13. Chuang CY, Chen TL, Cherng YG, Tai YT, Chen TG, Chen RM: Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondrion-dependent pathway. Arch Toxicol 2011;85:209-218.
14. Tai YT, Cherng YG, Chang CC, Hwang YP, Chen JT, Chen RM: Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/ c-Jun-mediated Bcl-2 gene expression and protein translocation. J Orthop Res 2007;25:625-635.
15. Pellegrini M, Baldari CT, Baldari: Apoptosis and oxidative stress-related diseases: the p66Shc connection. Curr Mol Med 2009;9:392-398.
16. Imai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000;403:795-800.
17. Yang T, Fu M, Pestell R, Sauve AA: SIRT1 and endocrine signaling. Trends Endocrinol Metab 2006;17:186-191.
18. Michan S, Sinclair D: Sinclair, Sirtuins in mammals: insights into their biological function. Biochem J 2007;404:1-13.
19. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W: Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001;107:137-148.
20. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004;305:390-392.
21. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-2015.
22. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L: Mammalian SIRT1 represses forkhead transcription factors. Cell 2004;116:551-563.
23. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaBdependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23:2369-2380.
24. Fujita M, Kuwano K, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T, Hara N: Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int Arch Allergy Immunol 1998;117:202-208.
25. Ma X, Xu D, Ai Y, Ming G, Zhao S: Fas inhibition attenuates lipopolysaccharide-induced apoptosis and cytokine release of rat type II alveolar epithelial cells. Mol Biol Rep 2010;37:3051-3056.
26. Song Y, Shi Y, Harken AH, Meng X: Induction of type II alveolar epithelial cells apoptosis in mouse by lipopolysaccharide does not require TNF-alpha. Chin Med J (Engl) 2003;116:625-629.
27. Chian CF, Chiang CH, Yuan-Jung C, Chuang CH, Liu SL, Yi-Han J, Zhang H, Ryu JH: Apocynin Attenuates Lipopolysaccharide-Induced Lung Injury in an Isolated and Perfused Rat Lung Model. Shock 2012;38:196-202.
28. Boots AW, Gerloff K, Bartholomé R, van Berlo D, Ledermann K, Haenen GR, Bast A, van Schooten FJ, Albrecht C, Schins RP: Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells. Biochim Biophys Acta 2012;1823:1151-1162.
29. Chen RM, Chou MW, Ueng TH: Induction of cytochrome P450 1A1 in human hepatoma HepG2 cells by 6-nitrochrysene. Toxicol Lett 2000;117:69-77.
30. Yamamoto H, Schoonjans K, Auwerx J: Auwerx, Sirtuin functions in health and disease. Mol Endocrinol 2007;21:1745-1755.
31. Kong XX, Wang R, Liu XJ, Zhu LL, Shao D, Chang YS, Fang FD: Function of SIRT1 in physiology. Biochemistry (Mosc) 2009;74:703-708.
32. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA: hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149-159.
33. Gu J, Song ZP, Gui DM, Hu W, Chen YG, Zhang DD: Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Lymphoma Nude Mice by Heme Oxygenase-1 Induction. Cardiovasc Toxicol 2012;12:341-349.
34. Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W: SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 2011;301:F427-435.
35. Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, Park JW, Kwon KB, Park BH: Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009;58:344-351.